Wells Fargo raised the firm’s price target on McKesson (MCK) to $914 from $816 and keeps an Equal Weight rating on the shares. The firm is updating its model following Q2 2026 earnings and increasing its tests following core pharma distribution and prescription technology strength.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK: